Prevention of early mortality by presumptive TB treatment

Authors
Category Primary study
Registry of TrialsPan African Clinical Trials Registry
Year 2011
INTERVENTION: ART only TB medication + ART CONDITION: ; HIV/AIDS ; Tuberculosis HIV/AIDS Tuberculosis PRIMARY OUTCOME: ¿ All‐cause mortality in the first 24 weeks after initiation of ART SECONDARY OUTCOME: causes of death Pulmonary TB (based on available clinical and laboratory information including smear examination, culture, chest X‐ray, and clinical assessment) sensitivity and specificity of clinical predictors (symptoms, signs, laboratory parameters) for incident unmasking TB unmasking TB INCLUSION CRITERIA: At least 18 years of age. HIV‐1 infected as documented and confirmed by a licensed rapid test for HIV‐1 antibodies or HIV‐1 antibody ELISA. Eligible for antiretroviral treatment with CD4 T cell count<50 cells/µl. BMI <18 kg/m2 Ability to understand and provide written informed consent for the study.
Epistemonikos ID: e3aa6cd86ba109a2a5f980deb596a312a0dec361
First added on: Aug 22, 2024